Using a Conversation Game to Engage Native American Washoe Tribe Members in Advance Care Planning: Preparation for a Clinical Trial

February 26, 2026 updated by: Lauren Van Scoy, Milton S. Hershey Medical Center

The goal of this study is to learn if a culturally adapted version of the Hello game, an advance care planning (ACP) conversation tool, is feasible and acceptable for use with members of the Washoe Tribe. The main questions it aims to answer are:

Can the Hello game be successfully adapted to reflect the cultural values, beliefs, and storytelling traditions of the Washoe Tribe?

Does playing the adapted Hello game increase ACP engagement and advance directive (AD) completion among Washoe Tribe members within 3 months?

Participants will:

  • Take part in talking circles at one of four Washoe reservations to share their beliefs, motivations, and experiences related to end-of-life care and advance care planning
  • Complete brief questionnaires about their ACP attitudes and behaviors
  • Play the culturally adapted Hello game in a group setting
  • Complete follow-up measures of ACP engagement and advance directive completion 3 months after playing the game

Study Overview

Study Type

Interventional

Enrollment (Estimated)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18 years or older
  • Member of the Washoe American Indian Tribe
  • Able to attend in-person events
  • Speaks, reads, and writes in English
  • Able to provide informed consent

Exclusion Criteria:

  • Under 18 years of age
  • Non-Tribal member
  • Non-English speaking
  • Unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Advance Care Planning Talking Circles
To expand study partnership with the Washoe tribe to further explore the needs, motivations, and barriers related to ACP and end-of-life decision-making for Tribal members and explore how findings converge or diverge from Western culture and across Washoe reservations. 2 talking circles (qualitative focus groups) will be conducted at each of the 4 Washoe reservations (n=8 groups, 48 individuals) along with brief questionnaires to: 1) explore beliefs about and motivations for ACP; 2) determine if and how storytelling plays a role in ACP; and 3) define meaningful and culturally appropriate ACP outcomes for the Washoe tribe.
Other: Arm 2: Modified Hello Game Play
Adapt and pilot test the Hello conversation game for use by the Washoe Tribe while establishing procedures for measuring the game's impact on ACP engagement. This objective includes: a) incorporating tribal recommendations to culturally adapt the game based on findings from objective 1, and b) conducting a feasibility and acceptability study of the modified game with 60 Washoe tribal members (15 from each reservation) using convergent mixed methods to assess preliminary outcomes and refine procedures for the future clinical trial.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arm 1: Qualitative themes describing Advance Care Planning needs, motivations, and challenges
Time Frame: During qualitative focus groups (up to 2 hours)
Participants will take part in qualitative focus groups, where they will verbally answer questions in a conversational format. These conversations will be audio recorded and qualitatively analyzed. Demographic information will be collected along with contact information. No validated survey measures will be used to collect data at this time point. Only qualitative data, demographics and contact information.
During qualitative focus groups (up to 2 hours)
Arm 2: Initial Enrollment Subject Numbers
Time Frame: RA Observed during participation in Hello game event (up to 1 hour)
Feasibility metric (Observed by Research Assistant) - How many participants actually enrolled.
RA Observed during participation in Hello game event (up to 1 hour)
Arm 2: Retention at 3-month follow-up
Time Frame: RA Observed during 3-month follow-up event (up to 1 hour)
Feasibility metric (Observed by Research Assistant) - # of participants who attended the follow-up event.
RA Observed during 3-month follow-up event (up to 1 hour)
Arm 2: Acceptability Score
Time Frame: During participation in Hello Game Event (up to 1 hour)
Feasibility metric; participants will fill out Conversation Acceptability measure to determine acceptability of playing the Hello game. The Acceptability measure consists of 3 items; 2 items on a Likert scale from 1-7 with 1 being Strongly Agree and 7 being Strongly Disagree, and 1 item indicating likelihood of recommending conversation activity to others on a scale of 0-10 with 0 being not likely at all and 10 being extremely likely.
During participation in Hello Game Event (up to 1 hour)
Arm 2: ACP engagement survey score Time 1
Time Frame: During participation in Hello Game Event (up to 1 hour)
Participants will be asked to fill out the validated ACP engagement survey to determine engagement and readiness levels for ACP actions. The ACP engagement survey consists of 4 items asking questions related to readiness for ACP behaviors. 2 items are on a scale of 1-5 with 1 being "I have never thought about it" and 5 being "I already have done it". The other 2 items are on a scale of 1-6 with 1 being "I have never thought about it" and 6 being "I have already done it (more than 5 years ago)".
During participation in Hello Game Event (up to 1 hour)
Arm 2: ACP engagement survey score Time 2
Time Frame: 3-months post game attendance (up to 1 hour)
Participants will be asked to fill out the validated ACP engagement survey to determine engagement and readiness levels for ACP actions. The ACP engagement survey consists of 4 items asking questions related to readiness for ACP behaviors. 2 items are on a scale of 1-5 with 1 being "I have never thought about it" and 5 being "I already have done it". The other 2 items are on a scale of 1-6 with 1 being "I have never thought about it" and 6 being "I have already done it (more than 5 years ago)".
3-months post game attendance (up to 1 hour)
Arm 2: ACP Behavior completion
Time Frame: 3-months post game attendance (up to 1 hour)
Participants will be asked to fill out the questions related to ACP behaviors. 6-items will be asked with 1 having options of yes/no/not sure/did not answer; 2 being yes/no/N/A/did not answer; 2 with options yes/no/did not answer and 1 with options nursing home/long-term care/insurance/hospice or palliative/funeral planning/other/did not report/did not answer
3-months post game attendance (up to 1 hour)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lauren J Van Scoy, MD, Penn State University - Hershey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2028

Study Registration Dates

First Submitted

February 23, 2026

First Submitted That Met QC Criteria

February 23, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 2, 2026

Last Update Submitted That Met QC Criteria

February 26, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00027799
  • 1R34NR021940-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data (IPD) collected during the study will be made available upon request following publication of research manuscripts. Data will include quantitative measures (demographics, social determinants of health, ACP engagement, intervention acceptability, and conversation satisfaction) and associated documentation. In alignment with Washoe Tribal sovereignty, all data sharing decisions require written approval from both the Principal Investigator and the Washoe Tribal Council, who retain ultimate authority over data access and reuse. Linkage sheets will not be shared and will be returned to the Washoe Tribe or destroyed upon study completion. Only de-identified data (identified by study ID only) will be shared in accordance with Penn State and NIH policies.

IPD Sharing Time Frame

De-identified data will be made available upon request and written approval from the PI and Washoe Tribal Council following publication of research manuscripts and will remain available for the life of the repository (minimum 10 years for ScholarSphere; indefinitely for openICPSR), or for as long as contact can be made with the PI.

IPD Sharing Access Criteria

Requests for de-identified individual participant data should be directed to the Principal Investigator. Access requires written approval from both the PI and the Washoe Tribal Council. Requestors should describe the purpose and proposed use of the data. Data will be provided in de-identified CSV format at no cost to the requestor.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gamification

Clinical Trials on Aim 1: Talking Circles

Subscribe